Irene Lagunes

Irene Lagunes

Auto-generated profile, based on publicly available information

Irene Lagunes

Universidad Veracruzana

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JRJesús M. Roldán-Peña
Jesús M. Roldán-Peña
DADaniel Alejandre-Ramos
Daniel Alejandre-Ramos
Óscar LópezÓscar López
Óscar López
IMInés Maya
Inés Maya
ILIrene Lagunes
Irene Lagunes
JFJosé G. Fernadez-Bolanos
José G. Fernadez-Bolanos

1 April 2015 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
ILIrene Lagunes
Irene Lagunes
ÁTÁngel Trigos
Ángel Trigos

31 October 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PBPaloma Begines
Paloma Begines
LSLucía Sevilla-Horrillo
Lucía Sevilla-Horrillo
APAdrián Puerta
Adrián Puerta
RPRebecca Puckett
Rebecca Puckett
SBSamuel Bayort
Samuel Bayort
JFJosé G. Fernadez-Bolanos
José G. Fernadez-Bolanos
Cancer accounts for one of the most complex diseases nowadays due to its multifactorial nature. Despite the vast number of cytotoxic agents developed so far, good therapeutic approaches are not always reached. In recent years, multitarget drugs are gaining great attention against multifactorial diseases in contraposition to polypharmacy. Herein we have accomplished the conjugation of phenolic derivatives with an ample number of organochalcogen motifs with the aim of developing novel antiproliferative agents. Their antioxidant, and antiproliferative properties (against six tumour and one non-tumour cell lines) were analysed. Moreover, in order to predict P-gp-mediated chemoresistance, the P-glycoprotein assay was also conducted in order to determine whether compounds prepared herein could behave as substrates of that glycoprotein. Selenium derivatives were found to be significantly stronger antiproliferative agents than their sulfur isosters. Moreover, the length and the nature of the tether, together with the nature of the organoselenium scaffold were also found to be crucial features in the observed bioactivities. The lead compound, bearing a methylenedioxyphenyl moiety, and a diselenide functionality, showed a good activity (GI50 = 0.88‒2.0 µM) and selectivity towards tumour cell lines (selectivity index: 14‒32); moreover, compounds considered herein were not substrates for the P-gp efflux pump, thus avoiding the development of chemoresistance coming from such mechanism, commonly found for widely-used chemotherapeutic agents.

25 August 2017 in Journal of Food Science
Verified
Journal Article
Closed access
PDF file
ILIrene Lagunes
Irene Lagunes
FVFernanda Vázquez‐Ortega
Fernanda Vázquez‐Ortega
ÁTÁngel Trigos
Ángel Trigos

10 March 2017 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
VAVerónica Luque Agudo
Verónica Luque Agudo
JAJ. Albarrán-Velo
J. Albarrán-Velo
JFJosé G. Fernadez-Bolanos
José G. Fernadez-Bolanos
Óscar LópezÓscar López
Óscar López
MLMark Light
Mark Light
MÁMaría Victoria Gil Álvarez
María Victoria Gil Álvarez
The Michael addition reactions of carbohydrate-derived nitroalkenes with ethyl thioglycolate and 2-mercaptobenzyl alcohol were studied. Reactions were conducted under mild, solvent-free conditions with DABCO as a catalyst, affording the corresponding adducts in good yields. Furthermore, compounds resulting from the addition with 2-mercaptobenzyl alcohol were used as starting materials for the synthesis of chiral 3-nitro-2H-thiochromenes. For some of the compounds synthesized herein, the antioxidant and antiproliferative activities against a panel of human solid tumor cell lines were assayed and compared with those of carbohydrate-nitroalkene substrates.

21 March 2016 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
HBHitesh A. Barad
Hitesh A. Barad
TSTushar R. Sutariya
Tushar R. Sutariya
GBGaurangkumar C. Brahmbhatt
Gaurangkumar C. Brahmbhatt
NPNarsidas J. Parmar
Narsidas J. Parmar
ILIrene Lagunes
Irene Lagunes
MYMange Ram Yadav
Mange Ram Yadav
A multicomponent reaction has been developed by incorporating quinoline-3-carbaldehyde, 1,3-cyclohexanedione and 2,3-diaminopyridine into some new quinolylpyrido[2,3-b][1,4]benzodiazepinone assemblies under catalyst- and solvent-free conditions at 120 °C. Further reaction of the resulting intermediates with allyl bromide led to the formation of the corresponding N5-allylated products, in situ, with higher yields in the same pot. Many candidates of this new class revealed noticeable activities against the representative human solid tumour cell lines A549 (lung), HBL-100 (breast), HeLa (cervix), SW1573 (lung), T-47D (breast) and WiDr (colon). The most active compounds resemble the standard drug etoposide in antiproliferative activity against HeLa, T-47D and WiDr cell lines. Docking studies in the active site of MDM2 led us to consider this protein a plausible target for the antiproliferative effects of the compounds.